<?xml version="1.0" encoding="UTF-8"?>
<list list-type="bullet">
 <list-item>
  <p>Assessment of the correlation between the amount of TILs in the biopsy and the total white blood cell count (WBC), ANC, ALC, absolute platelet count (APC), and PLR routinely assessed in women with TNBC, at diagnosis.</p>
 </list-item>
 <list-item>
  <p>Assessment of the correlation between the mentioned blood counts and their ratios (NLR and PLR), at the time of diagnosis, and the response to NACT according to Sataloff.
   <sup>[
    <xref rid="R15" ref-type="bibr">15</xref>]
   </sup>
  </p>
 </list-item>
 <list-item>
  <p>Assessment of the correlation between the mentioned blood counts and their ratios (NLR and PLR) at the time of diagnosis, and the TIL amount in the post-NACT surgical specimen.</p>
 </list-item>
 <list-item>
  <p>Assessment of the correlation between the mentioned blood counts and their ratios (NLR and PLR) and the recurrence-free survival (RFS).</p>
 </list-item>
 <list-item>
  <p>Assessment of the correlation between the mentioned blood counts and their ratios (NLR and PLR) before post-NACT surgery and TIL quantity in the surgical specimen post-NACT, depending on the time between surgery and the last administration of chemotherapy.</p>
 </list-item>
 <list-item>
  <p>Assessment of the correlation between the mentioned blood counts and their ratios (NLR and PLR) and the presence of ctDNA.</p>
 </list-item>
 <list-item>
  <p>Assessment of the correlation between ctDNA and RFS.</p>
 </list-item>
 <list-item>
  <p>Assessment of the correlation between the mentioned blood counts and their ratios (NLR and PLR) after cancer treatment and the RFS.</p>
 </list-item>
</list>
